These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 14517921)

  • 1. Designer stents and restenosis.
    Vetrovec GW
    Catheter Cardiovasc Interv; 2003 Oct; 60(2):179. PubMed ID: 14517921
    [No Abstract]   [Full Text] [Related]  

  • 2. Study of antirestenosis with the BiodivYsio dexamethasone-eluting stent (STRIDE): a first-in-human multicenter pilot trial.
    Liu X; Huang Y; Hanet C; Vandormael M; Legrand V; Dens J; Vandenbossche JL; Missault L; Vrints C; De Scheerder I
    Catheter Cardiovasc Interv; 2003 Oct; 60(2):172-8; discussion 179. PubMed ID: 14517920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is zero enough?
    Gonschior P
    J Invasive Cardiol; 2002 Sep; 14(9):514. PubMed ID: 12205349
    [No Abstract]   [Full Text] [Related]  

  • 4. Sirolimus-eluting stent implantation in a heart transplant recipient.
    Tomai F; Gagliardi G; Proietti I
    Ital Heart J; 2004 May; 5(5):408-9. PubMed ID: 15185909
    [No Abstract]   [Full Text] [Related]  

  • 5. Preventing restenosis with stent drug coatings.
    Belardi J
    J Invasive Cardiol; 2002 Sep; 14(9):576-82. PubMed ID: 12369563
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug-eluting stents for the prevention of restenosis: Standing the test of time.
    Carter AJ
    Catheter Cardiovasc Interv; 2002 Sep; 57(1):69-71. PubMed ID: 12203932
    [No Abstract]   [Full Text] [Related]  

  • 7. Seeing transient regional myocardial ischaemia through new eyes.
    Hatrick R; Teece S; Curzen N
    Int J Cardiovasc Intervent; 2005; 7(3):155-8. PubMed ID: 16243739
    [No Abstract]   [Full Text] [Related]  

  • 8. Randomized trial versus registry data--comparing apples and ORCHIDs.
    Moliterno DJ
    Catheter Cardiovasc Interv; 2006 Nov; 68(5):669-70. PubMed ID: 17039505
    [No Abstract]   [Full Text] [Related]  

  • 9. Overview: drug eluting stents.
    Dauerman HL
    Coron Artery Dis; 2006 Dec; 17(8):657-9. PubMed ID: 17119372
    [No Abstract]   [Full Text] [Related]  

  • 10. Large pseudoaneurysm after left main trunk stenting sealed by polytetrafluorethylene-covered stent.
    Nameki M; Ishiwata S; Momomura S
    Catheter Cardiovasc Interv; 2003 Oct; 60(2):233-5. PubMed ID: 14517932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug eluting stents for everyone and everything?
    Laham RJ
    Catheter Cardiovasc Interv; 2005 Dec; 66(4):512-3. PubMed ID: 16270362
    [No Abstract]   [Full Text] [Related]  

  • 12. Usefulness of high-pressure post-dilatation to optimize deployment of drug-eluting stents for the treatment of diffuse in-stent coronary restenosis.
    Blackman DJ; Porto I; Shirodaria C; Channon KM; Banning AP
    Am J Cardiol; 2004 Oct; 94(7):922-5. PubMed ID: 15464678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Very late [corrected] thrombosis of a sirolimus-eluting stent.
    Henderson D; Gunalingam B
    Catheter Cardiovasc Interv; 2006 Sep; 68(3):406-8. PubMed ID: 16892439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons from the E-SIRIUS trial.
    Schofer J
    Ital Heart J; 2004 Jan; 5(1):1-2. PubMed ID: 15080572
    [No Abstract]   [Full Text] [Related]  

  • 15. Day in and day out.
    Holmes DR
    Catheter Cardiovasc Interv; 2004 May; 62(1):30. PubMed ID: 15103596
    [No Abstract]   [Full Text] [Related]  

  • 16. Promise and challenges of bioabsorbable stents.
    Waksman R
    Catheter Cardiovasc Interv; 2007 Sep; 70(3):407-14. PubMed ID: 17722019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the end of restenosis the beginning of a new era?
    Moses JW
    Ital Heart J; 2004 Feb; 5(2):81-4. PubMed ID: 15086136
    [No Abstract]   [Full Text] [Related]  

  • 18. Outcome in the real-world of coronary high-risk intervention with drug-eluting stents (ORCHID) -- a single-center study comparing Cypher sirolimus-eluting with Taxus paclitaxel-eluting stents.
    Kumar S; Suresh V; Prendergast BD; Brooks NH; Wicks P; Levy RD; Ray SG; Bennett DH; Lee HS
    Catheter Cardiovasc Interv; 2006 Nov; 68(5):663-8. PubMed ID: 17034063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on bioabsorbable stents: from bench to clinical.
    Waksman R
    J Interv Cardiol; 2006 Oct; 19(5):414-21. PubMed ID: 17020566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of stent fracture as a cause of coronary restenosis after sirolimus-eluting stent implantation.
    Lee SH; Park JS; Shin DG; Kim YJ; Hong GR; Kim W; Shim BS
    Am J Cardiol; 2007 Aug; 100(4):627-30. PubMed ID: 17697818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.